---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-032231"
form_type: "8-K"
ticker: "APGE"
cik: "0001974640"
company_name: "Apogee Therapeutics, Inc."
filed_at: "2026-08-11T20:00:59+00:00"
generated_at: "2026-08-11T20:02:40.042956+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Apogee stockholders approve AbbVie merger; advisory comp proposal fails

## Summary
- Merger proposal approved: 46,508,107 for, 3,885 against, 14,261 abstentions, satisfying a closing condition.
- Non-binding compensation proposal failed: 19,323,605 for vs 27,123,259 against; not a condition to close.
- All seven directors (Henderson, McKenna, Bollinger, Fox, Jones, Kiselak, Shah) to resign effective at merger close.
- Special meeting quorum: 46,526,253 shares (74.87% of 62,140,183 outstanding) present.
- Apogee to become indirect wholly-owned subsidiary of AbbVie upon merger completion.

## SEC filing metadata
- accession: 0001140361-26-032231
- form_type: 8-K
- ticker: APGE
- cik: 0001974640
- company_name: Apogee Therapeutics, Inc.
- filed_at: 2026-08-11T20:00:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1974640/000114036126032231/0001140361-26-032231-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1974640/000114036126032231/ef20079870_form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-032231
- JSON: https://secwatch.observer/filing/0001140361-26-032231.json
- Plain text: https://secwatch.observer/filing/0001140361-26-032231.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.